Cargando…
Safety assessment of fluorescently labeled anti-EGFR Nanobodies in healthy dogs
Introduction: Surgical resection is one of the main treatment options for several types of cancer, the desired outcome being complete removal of the primary tumor and its local metastases. Any malignant tissue that remains after surgery may lead to relapsing disease, negatively impacting the patient...
Autores principales: | do Valle, Nayra Cristina Herreira, Janssen, Simone, Stroet, Marcus C. M., Pollenus, Sofie, Van den Block, Sonja, Devoogdt, Nick, Debacker, Jens M., Hernot, Sophie, De Rooster, Hilde |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538052/ https://www.ncbi.nlm.nih.gov/pubmed/37781693 http://dx.doi.org/10.3389/fphar.2023.1266288 |
Ejemplares similares
-
Targeted Nanobody-Based Molecular Tracers for Nuclear Imaging and Image-Guided Surgery
por: Debie, Pieterjan, et al.
Publicado: (2019) -
The Design and Preclinical Evaluation of a Single-Label Bimodal Nanobody Tracer for Image-Guided Surgery
por: Debie, Pieterjan, et al.
Publicado: (2021) -
Near-Infrared Fluorescence Imaging of Pancreatic Cancer Using a Fluorescently Labelled Anti-CEA Nanobody Probe: A Preclinical Study
por: van Manen, Labrinus, et al.
Publicado: (2023) -
The GEM-handle as convenient labeling strategy for bimodal single-domain antibody-based tracers carrying (99m)Tc and a near-infrared fluorescent dye for intra-operative decision-making
por: Declerck, Noemi B., et al.
Publicado: (2023) -
Immunogenicity Risk Profile of Nanobodies
por: Ackaert, Chloé, et al.
Publicado: (2021)